Bone Therapeutics and Asahi Kasei Sign Exclusive License Agreement for PREOB

Bone Therapeutics signed an exclusive, royalty-bearing license agreement with Asahi Kasei to develop and commercialize PREOB® autologous bone cell therapy in Japan, with an option to include China, Korea and Taiwan.

Bone Therapeutics will provide manufacturing expertise, while Asahi Kasei will gain exclusive rights to develop,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us